GlassScriptPhysician profile
Joanne B Rogin
NPI 1528006418
$60,746.19
in general payments reported to CMS, 2019-2025
13 companies · $265 in 2025
The $265 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $13K · 2021: $6,693 · 2022: $14K · 2023: $1,887 · 2024: $4,170 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,600 · Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,600.00 |
| Food and Beverage | $722.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $23,680.43 | 2020-2024 | |
| Eisai INC. | $16,233.20 | 2019 | |
| Sunovion Pharmaceuticals INC. | $6,751.57 | 2019-2022 | |
| Catalyst Pharmaceuticals, INC. | $5,652.53 | 2023-2024 | Fycompa |
| Ucb, INC. | $5,485.21 | 2019-2025 | Briviact |
| Ucb Sa | $1,550.00 | 2019 | |
| Aquestive Therapeutics, INC. | $1,020.00 | 2021 | |
| Jazz Pharmaceuticals INC. | $281.91 | 2022-2025 | |
| Greenwich Biosciences, INC. | $50.00 | 2019 | |
| Acadia Pharmaceuticals INC | $24.00 | 2025 | Daybue |
| Ge Healthcare | $17.34 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Rogin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.